Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)
Clinical trial NCT03179436 · COMPLETED
Trial details
- NCT number
- NCT03179436
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-02
- Primary completion
- 2024-04-08
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.